Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

US Patent 8575125 · Granted Nov 5, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and pharmaceutical compositions for the treatment of fibrosis2018
Use of antagonists of the CBI receptor for the manufacture of a composition usef2013
Use of antagonists of the CBI receptor for the manufacture of a composition usef2013
Use of antagonists of the CB1 receptor for the manufacture of a composition usef2012
Use of antagonists of the CB1 receptor for the manufacture of a composition usef2012
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
Method of treating insulin resistance with a selective inhibitor of CB2 receptor2011
CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antif2011